Biotech firm suffers setback in multi-million pound patent battle
Manchester-based biotech company Premaitha Health has suffered a setback in a multi-million pound legal battle with an American company over the patent of its ground-breaking non-invasive prenatal test for Downs syndrome in unborn children, branded IONA.
A High Court ruling delivered today (Tuesday, November 21) has deemed the IONA test infringes the company Illumina Inc’s patent in “certain respects”.
The judgment also refused the company's application for declarations of non-infringement in respect of two proposed alte... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
